|
[1]
|
徐小元, 丁惠国, 李文刚, 等. 肝硬化肝性脑病诊疗指南[J]. 临床肝胆病杂志, 2018, 34(10): 2076-2089.
|
|
[2]
|
Weissenborn, K. (2019) Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs, 79, 5-9. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Elsaid, M.I. and Rustgi, V.K. (2020) Epidemiology of Hepatic Encephalopathy. Clinics in Liver Disease, 24, 157-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Chen, Z.F., Ruan, J.S., Li, D.H., et al. (2021) The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy. Frontiers in Cellular and Infection Microbiology, 10, 595759. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hoilat, G.J., Ayas, M.F., Hoilat, J.N., et al. (2021) Polyethylene Glycol versus Lactulose in the Treatment of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis. BMJ Open Gastroenterology, 8, e000648. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wang, Z.D., Chu, P. and Wang, W.J. (2018) Combination of Rifaximin and Lactulose Improves Clinical Efficacy and Mortality in Patients with Hepatic Encephalopathy. Drug Design, Development and Therapy, 13, 1-11. [Google Scholar] [CrossRef]
|
|
[7]
|
Nardelli, S., Gioia, S., Faccioli, J., et al. (2023) Hepatic Encephalopathy—Recent Advances in Treatment and Diagnosis. Expert Review of Gastroenterology & Hepatology, 17, 225-235. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Jain, A., Sharma, B.C., Mahajan, B., et al. (2021) L-Ornithine L-Aspartate in Acute Treatment of Severe Hepatic Encephalopathy: A Double-Blind Randomized Controlled Trial. Hepatology, 75, 1194-1203. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
王军梅, 靳晓利. 微生态制剂辅助治疗肝硬化肝性脑病的疗效及对肠道菌群的影响[J]. 中国微生态学杂志, 2022, 34(1): 74-77, 90.
|
|
[10]
|
Bajaj, J.S., Fagan, A., Gavis, E.A., et al. (2019) Long-Term Outcomes of Fecal Microbiota Transplantation in Patients with Cirrhosis. Gastroenterology, 156, 1921-1923.e3. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Bajaj, J.S., Salzman, N.H., Acharya, C., et al. (2019) Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial. Hepatology, 70, 1690-1703. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
陈功海, 王广川, 张春清. 经颈静脉肝内门体分流术后肝性脑病的研究现状[J]. 临床肝胆病杂志, 2021, 37(5): 1201-1204.
|
|
[13]
|
李晶滢, 辛喜艳, 杨华升. 钱英辨治轻微型肝性脑病经验[J]. 中华中医药杂志, 2021, 36(7): 4022-4024.
|
|
[14]
|
钱斐, 薛博瑜, 王培, 等. 薛博瑜防治肝性脑病五法[J]. 中华中医药杂志, 2020, 35(4): 1817-1820.
|
|
[15]
|
蒋云霞, 罗伟生. 大黄及其提取物治疗肝脏疾病研究进展[J]. 山东中医杂志, 2020, 39(12): 1365-1368.
|
|
[16]
|
刘天华. 中西医结合治疗肝硬化轻微肝性脑病临床疗效观察[J]. 辽宁中医杂志, 2022, 49(1): 109-112.
|
|
[17]
|
范铭兴, 张曾娣, 缪红军. 安宫牛黄丸联合醒脑静注射液治疗肝性脑病临床观察[J]. 中华中医药学刊, 2020, 38(2): 237-240.
|
|
[18]
|
苗芙蕊, 麦威, 蒋筱. 隔姜灸期门、中脘穴对轻微型肝性脑病模型大鼠肝功能及脑内GSH-PX、CAT活力、LRP1表达的影响[J]. 时珍国医国药, 2021, 32(11): 2807-2810.
|
|
[19]
|
黄姬玲, 康英杰, 成建明, 等. 电针干预轻微型肝性脑病即刻脑效应的BOLD-fMRI研究[J]. 中国医学计算机成像杂志, 2022, 28(2): 119-126.
|